Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €58.58 EUR
Change Today -1.65 / -2.74%
Volume 92.1K
ORP On Other Exchanges
Symbol
Exchange
Berlin
EN Paris
OTC US
EN Paris
As of 11:39 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

orpea (ORP) Snapshot

Open
€60.18
Previous Close
€60.23
Day High
€60.18
Day Low
€58.55
52 Week High
03/25/15 - €61.49
52 Week Low
10/16/14 - €42.82
Market Cap
3.5B
Average Volume 10 Days
98.6K
EPS TTM
€2.46
Shares Outstanding
55.6M
EX-Date
--
P/E TM
23.9x
Dividend
€0.80
Dividend Yield
1.19%
Current Stock Chart for ORPEA (ORP)

Related News

No related news articles were found.

orpea (ORP) Related Businessweek News

No Related Businessweek News Found

orpea (ORP) Details

ORPEA Société Anonyme operates long-term care facilities (nursing homes), post-acute and rehabilitation clinics, and psychiatric care clinics. It operates in two segments, France and International. The company operates nursing homes in France, Belgium, Italy, and Spain; multi-disciplinary and specialist post-acute and rehabilitation care facilities in France and Switzerland; and general psychiatric clinics in France, Italy, and Switzerland. Its care facilities provide care and support services to residents; and logistical and residential services, such as accommodation, meals, laundry, room cleaning, and various entertainment activities. The company’s multi-disciplinary post-acute and rehabilitation care facilities offer physical medicine and physical therapy; orthopedic and trauma rehabilitation; hematology and oncology post-acute and rehabilitation care; geriatric post-acute and rehabilitation care; and other specialist services, such as care of chronic neurovegetative states and multi-functional medical services. Its psychiatric clinics provide services for the patients with acute mental pathologies, such as mood disorders, anxiety disorders, addiction, overuse or burnout syndromes, chronic fatigue syndrome, fibromyalgia, sleep disorders, eating disorders, borderline personality disorders, age-related psychiatric disorders, and certain psychotic disorders. As of February 11, 2015, the company had a network of 579 healthcare facilities with 56,314 beds. ORPEA Société Anonyme was founded in 1989 and is headquartered in Puteaux, France.

Founded in 1989

orpea (ORP) Top Compensated Officers

Chief Executive Officer, Chief Financial Offi...
Total Annual Compensation: €995.0K
Deputy Chief Executive Officer, Chief Operati...
Total Annual Compensation: €729.0K
Compensation as of Fiscal Year 2013.

orpea (ORP) Key Developments

ORPEA Société Anonyme Announces Audited Consolidated Earnings Results for the Year Ended December 31, 2014; Provides Financial Guidance for 2015

ORPEA Société Anonyme announced audited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported revenues of EUR 1,948.6 million compared to EUR 1,607.9 million a year ago. EBITDAR (Recurring EBITDA before rent) was EUR 537.8 million compared to EUR 433.2 million a year ago. Recurring EBITDA was EUR 350.1 million compared to EUR 298.0 million a year ago. Recurring operating profit was EUR 271.2 million compared to EUR 227.3 million a year ago. Operating profit was EUR 308.9 million compared to EUR 268.4 million a year ago. Profit before tax was EUR 209.8 million compared to EUR 177.8 million a year ago. Attributable net profit was EUR 136.3 million compared to EUR 116.9 million a year ago. For 2015, the company forecast revenues of EUR 2,310 million (i.e. growth of 18.6%), not including any other potential developments, plus sound profitability and a debt firmly under control with a lower average cost of debt.

ORPEA Société Anonyme Proposes Dividend for the Year 2014

At the Annual General Meeting on June 23, 2015, the Board of Directors of ORPEA Société Anonyme will propose a dividend of €0.80 per share in respect of the 2014 financial year, compared with €0.70 for the previous financial year.

ORPEA Announces Sales for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Revenue Guidance for 2015

ORPEA announced its sales for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported total sales of €533.4 million against €418.9 million a year ago. For the full year, the company reported total sales of €1,948.4 million against €1,607.9 million a year ago. The company now forecasts 2015 revenues of €2,310 million, implying strong growth of 18.6% (increase of €361.6 million), including robust organic growth. This objective includes a full-year contribution from Senevita and SilverCare and a 9-month contribution from SeneCura, as well as the growth secured to date.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ORP:FP €58.58 EUR -1.65

ORP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Korian-Medica €31.48 EUR -0.62
Le Noble Age €19.67 EUR -0.12
Maternus-Kliniken AG €0.78 EUR -0.009
RHOEN-KLINIKUM AG €24.49 EUR -0.71
View Industry Companies
 

Industry Analysis

ORP

Industry Average

Valuation ORP Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 13.5x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORPEA, please visit www.orpea-corp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.